Abstract
Attention deficit hyperactivity disorder (ADHD) is a psychiatric disorder that affects ∼5% of school-aged children; however, the mechanisms underlying ADHD remain largely unclear. Here we report a previously unidentified association between G protein–coupled receptor kinase–interacting protein-1 (GIT1) and ADHD in humans. An intronic single-nucleotide polymorphism in GIT1, the minor allele of which causes reduced GIT1 expression, shows a strong association with ADHD susceptibility in humans. Git1-deficient mice show ADHD-like phenotypes, with traits including hyperactivity, enhanced electroencephalogram theta rhythms and impaired learning and memory. Hyperactivity in Git1−/− mice is reversed by amphetamine and methylphenidate, psychostimulants commonly used to treat ADHD. In addition, amphetamine normalizes enhanced theta rhythms and impaired memory. GIT1 deficiency in mice leads to decreases in ras-related C3 botulinum toxin substrate-1 (RAC1) signaling and inhibitory presynaptic input; furthermore, it shifts the neuronal excitation-inhibition balance in postsynaptic neurons toward excitation. Our study identifies a previously unknown involvement of GIT1 in human ADHD and shows that GIT1 deficiency in mice causes psychostimulant-responsive ADHD-like phenotypes.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Early loss of Scribble affects cortical development, interhemispheric connectivity and psychomotor activity
Scientific Reports Open Access 27 April 2021
-
Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts
BMC Medical Genomics Open Access 28 October 2020
-
ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem
Translational Psychiatry Open Access 21 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Barkley, R.A. Attention deficit hyperactivity disorder. A Handbook for Diagnosis and Treatment. 3rd ed. (Guilford, New York, 2006).
Swanson, J.M. et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol. Rev. 17, 39–59 (2007).
Bakker, S.C. et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet. 72, 1251–1260 (2003).
Fisher, S.E. et al. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet. 70, 1183–1196 (2002).
Ogdie, M.N. et al. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am. J. Hum. Genet. 75, 661–668 (2004).
Ogdie, M.N. et al. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am. J. Hum. Genet. 72, 1268–1279 (2003).
Zhou, K. et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147B, 1392–1398 (2008).
Arcos-Burgos, M. et al. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet. 75, 998–1014 (2004).
Franke, B., Neale, B.M. & Faraone, S.V. Genome-wide association studies in ADHD. Hum. Genet. 126, 13–50 (2009).
Premont, R.T. et al. beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc. Natl. Acad. Sci. USA 95, 14082–14087 (1998).
Claing, A. et al. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc. Natl. Acad. Sci. USA 97, 1119–1124 (2000).
Hoefen, R.J. & Berk, B.C. The multifunctional GIT family of proteins. J. Cell Sci. 119, 1469–1475 (2006).
Albertinazzi, C., Za, L., Paris, S. & de Curtis, I. ADP-ribosylation factor 6 and a functional PIX/p95–APP1 complex are required for Rac1B-mediated neurite outgrowth. Mol. Biol. Cell 14, 1295–1307 (2003).
Za, L. et al. betaPIX controls cell motility and neurite extension by regulating the distribution of GIT1. J. Cell Sci. 119, 2654–2666 (2006).
Segura, I., Essmann, C.L., Weinges, S. & Acker-Palmer, A. Grb4 and GIT1 transduce ephrinB reverse signals modulating spine morphogenesis and synapse formation. Nat. Neurosci. 10, 301–310 (2007).
Zhang, H., Webb, D.J., Asmussen, H., Niu, S. & Horwitz, A.F.A. GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J. Neurosci. 25, 3379–3388 (2005).
Zhang, H., Webb, D.J., Asmussen, H. & Horwitz, A.F. Synapse formation is regulated by the signaling adaptor GIT1. J. Cell Biol. 161, 131–142 (2003).
Menon, P. et al. Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice. Brain Res. 1317, 218–226 (2010).
Saneyoshi, T. et al. Activity-dependent synaptogenesis: regulation by a CaM-kinase kinase/CaM-kinase I/betaPIX signaling complex. Neuron 57, 94–107 (2008).
Kim, S. et al. The GIT family of proteins forms multimers and associates with the presynaptic cytomatrix protein Piccolo. J. Biol. Chem. 278, 6291–6300 (2003).
Ko, J. et al. Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. J. Neurosci. 23, 1667–1677 (2003).
Schmalzigaug, R. et al. Impaired fear response in mice lacking GIT1. Neurosci. Lett. 458, 79–83 (2009).
Goehler, H. et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol. Cell 15, 853–865 (2004).
Barkley, R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 121, 65–94 (1997).
Gilden, D.L. & Hancock, H. Response variability in attention-deficit disorders. Psychol. Sci. 18, 796–802 (2007).
Castellanos, F.X. & Tannock, R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3, 617–628 (2002).
Russell, V.A. Reprint of “Neurobiology of animal models of attention-deficit hyperactivity disorder.” J. Neurosci. Methods 166, I–XIV (2007).
Gainetdinov, R.R. et al. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397–401 (1999).
Hess, E.J., Collins, K.A. & Wilson, M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J. Neurosci. 16, 3104–3111 (1996).
Barry, R.J., Clarke, A.R. & Johnstone, S.J. A review of electrophysiology in attention-deficit/hyperactivity disorder: I. Qualitative and quantitative electroencephalography. Clin. Neurophysiol. 114, 171–183 (2003).
Düzel, E., Penny, W.D. & Burgess, N. Brain oscillations and memory. Curr. Opin. Neurobiol. 20, 143–149 (2010).
Uhlhaas, P.J. & Singer, W. Abnormal neural oscillations and synchrony in schizophrenia. Nat. Rev. Neurosci. 11, 100–113 (2010).
Clarke, A.R., Barry, R.J., Bond, D., McCarthy, R. & Selikowitz, M. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl.) 164, 277–284 (2002).
Feng, Q., Albeck, J.G., Cerione, R.A. & Yang, W. Regulation of the Cool/Pix proteins: key binding partners of the Cdc42/Rac targets, the p21-activated kinases. J. Biol. Chem. 277, 5644–5650 (2002).
Chavrier, P. & Goud, B. The role of ARF and Rab GTPases in membrane transport. Curr. Opin. Cell Biol. 11, 466–475 (1999).
Donaldson, J.G. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J. Biol. Chem. 278, 41573–41576 (2003).
Daly, G., Hawi, Z., Fitzgerald, M. & Gill, M. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry 4, 192–196 (1999).
LaHoste, G.J. et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry 1, 121–124 (1996).
Bokoch, G.M. Biology of the p21-activated kinases. Annu. Rev. Biochem. 72, 743–781 (2003).
Boda, B., Nikonenko, I., Alberi, S. & Muller, D. Central nervous system functions of PAK protein family: from spine morphogenesis to mental retardation. Mol. Neurobiol. 34, 67–80 (2006).
Meyer, D.K. et al. Regulation of somatodendritic GABAA receptor channels in rat hippocampal neurons: evidence for a role of the small GTPase Rac1. J. Neurosci. 20, 6743–6751 (2000).
Cobos, I., Borello, U. & Rubenstein, J.L. Dlx transcription factors promote migration through repression of axon and dendrite growth. Neuron 54, 873–888 (2007).
Richter, K. et al. Presynaptic cytomatrix protein bassoon is localized at both excitatory and inhibitory synapses of rat brain. J. Comp. Neurol. 408, 437–448 (1999).
Barkley, R.A. A review of stimulant drug research with hyperactive children. J. Child Psychol. Psychiatry 18, 137–165 (1977).
Rosa-Neto, P. et al. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25, 868–876 (2005).
Südhof, T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903–911 (2008).
Tabuchi, K. et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71–76 (2007).
Deutsch, S.I., Rosse, R.B., Schwartz, B.L. & Mastropaolo, J. A revised excitotoxic hypothesis of schizophrenia: therapeutic implications. Clin. Neuropharmacol. 24, 43–49 (2001).
Fernandez, F. et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10, 411–413 (2007).
Kleschevnikov, A.M. et al. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24, 8153–8160 (2004).
Costa, R.M. et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415, 526–530 (2002).
Cui, Y. et al. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135, 549–560 (2008).
Shilyansky, C. et al. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc. Natl. Acad. Sci. USA 107, 13141–13146 (2010).
Kalanithi, P.S. et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc. Natl. Acad. Sci. USA 102, 13307–13312 (2005).
Moll, G.H., Heinrich, H. & Rothenberger, A. Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr. Scand. 107, 69–72 (2003).
Moll, G.H., Heinrich, H., Trott, G., Wirth, S. & Rothenberger, A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci. Lett. 284, 121–125 (2000).
Richter, M.M., Ehlis, A.C., Jacob, C.P. & Fallgatter, A.J. Cortical excitability in adult patients with attention-deficit/hyperactivity disorder (ADHD). Neurosci. Lett. 419, 137–141 (2007).
Pouget, P., Wattiez, N., Rivaud-Pechoux, S. & Gaymard, B. A fragile balance: perturbation of GABA mediated circuit in prefrontal cortex generates high intraindividual performance variability. PLoS ONE 4, e5208 (2009).
Kaufman, J. et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J. Am. Acad. Child Adolesc. Psychiatry 36, 980–988 (1997).
Kim, Y.S. et al. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia—Present and Lifetime Version—Korean version (K-SADS-PL-K). Yonsei Med. J. 45, 81–89 (2004).
Acknowledgements
We thank the Vector Integration Site Analysis service at the University of California–Davis Mouse Biology Program for providing the data on the single-copy status of the Git1 gene trap. This work was supported by the Korean National Creative Research Initiative program and WCU (World Class University) program (R31-2008-000-10071-0) funded by the Ministry of Education, Science, and Technology (to Eunjoon K.), the National Research Foundation of Korea (2010-0014162 to C.K. and 313-2007-2-C00630 to S.-Y.C.), the Basic Science Program through the National Research Foundation of Korea (2010-0002283 to J.K.), the Mid-career Researcher Program through the National Research Foundation of Korea (20100000032 to D.K.), the Seoul National University Hospital Research Fund (09-2008-001-0 to J.K.) and by a T.J. Park Doctoral Fellowship (to H.W.).
Author information
Authors and Affiliations
Contributions
Eunjin K. conducted the SNP experiments; J.-W.K., S.-C.C., B.-N.K. and M.-S.S. provided the ADHD and control samples and conducted clinical data analyses; E.-K.H. generated Git1−/− mice; M.-H.K. measured and analyzed minicurrents; S.C., J.S. and S.-Y.C. measured and analyzed evoked synaptic transmission; J.K., H.J. and J.J. contributed to EEG recordings; H.W. and W.M. conducted all the rest of the experiments; D.K., C.K. and Eunjoon K. supervised the project and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Figures 1–14 and Supplementary Tables 1–5 (PDF 1749 kb)
Rights and permissions
About this article
Cite this article
Won, H., Mah, W., Kim, E. et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat Med 17, 566–572 (2011). https://doi.org/10.1038/nm.2330
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2330
This article is cited by
-
Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility
Molecular Psychiatry (2022)
-
GIT1 is an untolerized autoantigen involved in immunologic disturbance of spermatogenesis
Histochemistry and Cell Biology (2022)
-
Early loss of Scribble affects cortical development, interhemispheric connectivity and psychomotor activity
Scientific Reports (2021)
-
Biomarker discovery in attention deficit hyperactivity disorder: RNA sequencing of whole blood in discordant twin and case-controlled cohorts
BMC Medical Genomics (2020)
-
ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem
Translational Psychiatry (2020)